Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

ClinicalTrials.gov ID: NCT00045968

Public ClinicalTrials.gov record NCT00045968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated. Patients must enter screening at a participating site prior to surgical resection of the tumor. Patients will receive the standard of care, including radiation and Temodar therapy and two out of three will additionally receive DCVax-L, with the remaining one third receiving a placebo. All patients will have the option to receive DCVax-L in a crossover arm upon documented disease progression. (note: DCVax-L when used for patients with brain cancer is sometimes also referred to as DCVax-Brain)

Study identification

NCT ID
NCT00045968
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Northwest Biotherapeutics
Industry
Enrollment
348 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Nov 2022 (Estimated)
Completion
Not listed
Last update posted
May 18, 2022

Started 2006

United States locations

U.S. sites
71
U.S. states
27
U.S. cities
59
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Sutter East Bay Neuroscience Institute-Eden Medical Center Castro Valley California 94546 —
City of Hope Duarte California 91010 —
UCSD Moores Cancer Center La Jolla California 93093 —
Kaiser Permanente - Los Angeles Los Angeles California 90027 —
UCLA Medical Center Los Angeles California 90095 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
St. Joseph Hospital of Orange Orange California 92868 —
University of California, Irvine Medical Center Orange California 92868 —
Kaiser Permanente - Redwood City Redwood City California 94063 —
Sutter Institute for Medical Research Sacramento California 95816 —
University of Colorado Cancer Center Aurora Colorado 80045 —
Colorado Neurological Institute Englewood Colorado 80113 —
Georgetown University Medical Center Washington D.C. District of Columbia 20057 —
University of Florida Gainesville Florida 32611 —
Memorial Cancer Institute Hollywood Florida 33021 —
Mount Sinai Community Clinical Oncology Program Miami Beach Florida 33140 —
Moffitt Cancer Center Tampa Florida 33612 —
Piedmont Atlanta Hospital Atlanta Georgia 30309 —
Rush University Medical Center Chicago Illinois 60612 —
Illinois Cancer Care Peoria Illinois 61615 —
Cadence Cancer Center Warrenville Illinois 60555 —
IU Simon Cancer Center Indianapolis Indiana 46202 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Markey Cancer Center/University of Kentucky Lexington Kentucky 40536 —
Norton Cancer Institute Louisville Kentucky 40202 —
Tufts Medical Center Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Michigan Cancer Center Ann Arbor Michigan 48109 —
Henry Ford Hospital Detroit Michigan 48202 —
Spectrum Health Grand Rapids Michigan 49503 —
John Nasseff Neuroscience Institute at Abbott Northwestern Hospital Minneapolis Minnesota 55407 —
St. Luke's Hospital Kansas City Missouri 64111 —
Washington University School of Medicine St Louis Missouri 63110 —
The Brain Tumor Center at JFK Medical Center Edison New Jersey 08818 —
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
The Valley Hospital Ridgewood New Jersey 07450 —
Overlook Hospital Summit New Jersey 07902 —
Capital Health Regional Medical Center Trenton New Jersey 08638 —
Long Island Brain Tumor Center at Neurological Surgery, P.C. Lake Success New York 11042 —
North Shore University Hospital Manhasset New York 11030 —
New York University Clinical Cancer Center New York New York 10016 —
Mount Sinai Medical Center New York New York 10029-6574 —
Columbia University Medical Center New York New York 10032 —
University of Rochester Medical Center Rochester New York 14642 —
Stony Brook Medicine Stony Brook New York 11794 —
Brain and Spine Surgeons of New York and Northern Westchester Hospital White Plains New York 10604 —
University of North Carolina, Chapel Hill Chapel Hill North Carolina 27514 —
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157 —
University of Cincinnati Cancer Institute Cincinnati Ohio 45267 —
University Hospitals Seidman Cancer Center Cleveland Ohio 44106 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State University Columbus Ohio 43210 —
OhioHealth Columbus Ohio 43214 —
Oklahoma University Health Science Center Oklahoma City Oklahoma 73104 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Jefferson Hospital for Neuroscience Philadelphia Pennsylvania 19107 —
Temple University School of Medicine Philadelphia Pennsylvania 19140 —
Rhode Island Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Hospitals and Clinics Charleston South Carolina 29425 —
Saint Thomas Research Institute Nashville Tennessee 37205 —
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 —
Baylor Research Institute Dallas Texas 75246 —
The Methodist Hospital Houston Texas 77030 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
Cancer Therapy & Research at University of Texas Health Science Center San Antonio San Antonio Texas 78229 —
Benaroya Research Institute at Virginia Mason Seattle Washington 98101 —
Swedish Hospital Neuroscience Research Seattle Washington 98122 —
Aurora Saint Luke's Medical Center Milwaukee Wisconsin 23215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00045968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00045968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →